Comparison between Nebulized Magnesium Sulphate (MgSO₄) Versus Nebulized Salbutamol in Acute Exacerbation of Asthma in Children: A Clinical Trial
DOI:
https://doi.org/10.70749/ijbr.v3i7.2361Keywords:
Nebulized Magnesium Sulphate, MgSO₄, Nebulized Salbutamol, Acute Exacerbation of Asthma, ChildrenAbstract
Objective: This study aimed to evaluate whether nebulized magnesium sulphate (MgSO₄) offers any clinical advantage over nebulized salbutamol in children presenting with acute asthma exacerbations. Methods: We carried out a six-month randomized controlled trial from September 2024 to March 2025 in the Paediatrics Department at Shaikh Zayed Hospital, Lahore. A total of 100 children between 2 and 12 years of age, all with moderate to severe exacerbations (Paediatric Asthma Severity Score [PASS] > 8), were recruited. Using a double-blind design, they were randomly assigned to receive either nebulized MgSO₄ (Group A, n=50) or nebulized salbutamol (Group B, n=50). Each child was given three nebulizations 20 minutes apart. The primary outcome was defined as a fall of at least 4 points in PASS after 6 hours. Results: The two groups were well matched at baseline, with mean ages of 7.1 ± 2.6 years in the MgSO₄ group and 7.4 ± 2.8 years in the salbutamol group, and a slight male predominance in both (60% and 58%, respectively). After six hours, children receiving MgSO₄ demonstrated a greater improvement: mean PASS dropped by 5.3 ± 1.4 points compared with 4.1 ± 1.6 points in the salbutamol group (p=0.002). A clinically meaningful response (≥4-point reduction) was achieved in 86% of children on MgSO₄ versus 68% on salbutamol (p=0.04). Oxygen saturation also rose more sharply in the MgSO₄ group, from 89.3% ± 3.4 to 96.8% ± 2.1, compared with an increase from 89.6% ± 3.6 to 95.2% ± 2.8 in the salbutamol group (p=0.03). No serious adverse effects were observed, apart from minor throat irritation in a few cases. Conclusion: Nebulized magnesium sulphate proved more effective than salbutamol alone in improving clinical outcomes for children with acute asthma exacerbations. Its ease of administration, safety profile, and low cost support its potential role as an adjunct therapy in routine pediatric emergency care.
Downloads
References
1. Sarmin, Z. U., Anwar, S., Khan, T. H., Mollah, M. A., Khanam, R., & Baki, S. A. (2020). Efficacy of nebulized magnesium sulphate in the treatment of acute bronchial asthma compared to nebulized salbutamol: A randomized control trial. Bangladesh Journal of Child Health, 44(1), 24-29.
https://doi.org/10.3329/bjch.v44i1.49683
2. Turker, S., Dogru, M., Yildiz, F., & Yilmaz, S. B. (2017). The effect of nebulised magnesium sulphate in the management of childhood moderate asthma exacerbations as adjuvant treatment. Allergologia et Immunopathologia, 45(2), 115-120.
https://doi.org/10.1016/j.aller.2016.10.003
3. Akter, T., Islam, M. N., Hoque, M. A., Khanam, S., Khan, H. A., & Saha, B. K. (2015). Nebulization by isotonic magnesium sulphate solution with salbutamol provide early and better response as compared to conventional approach (Salbutamol plus normal saline) in acute exacerbation of asthma in children. Faridpur Medical College Journal, 9(2), 61-67.
https://doi.org/10.3329/fmcj.v9i2.25675
4. Aggarwal, P., Dwivedi, S., & Handa, R. (2004). Nebulized magnesium sulfate and salbutamol combination compared to salbutamol alone in the treatment of acute bronchial asthma: A randomized study. Annals of Emergency Medicine, 44(4), S38.
https://doi.org/10.1016/j.annemergmed.2004.07.124
5. Özdemir, A., & Doğruel, D. (2020). Efficacy of magnesium sulfate treatment in children with acute asthma. Medical Principles and Practice, 29(3), 292-298.
https://doi.org/10.1159/000506595
6. Sarhan, H. A., EL-Garhy, O. H., Alhosseiny, M., & AlNokrashy, N. (2016). The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma. Drug Design, Development and Therapy, 1927.
https://doi.org/10.2147/dddt.s103147
7. Elrifai, A., Elsayad, M., & Hussein, H. (2020). Magnesium sulphate (MgSO4) nebulization versus salbutamol nebulization in acute asthmatic attacks in adults. Journal of Recent Advances in Medicine, 1(1), 39-45.
https://doi.org/10.21608/jram.2019.16002.1016
8. Akter, T., Islam, M. N., Hoque, M. A., Khanam, S., Khan, H. A., & Saha, B. K. (2015). Nebulization by isotonic magnesium sulphate solution with salbutamol provide early and better response as compared to conventional approach (Salbutamol plus normal saline) in acute exacerbation of asthma in children. Faridpur Medical College Journal, 9(2), 61-67.
https://doi.org/10.3329/fmcj.v9i2.25675
9. Emeryk, A., Janeczek, K., Markut-Miotła, E., Pirożyński, M., & Florkiewicz, E. (2022). Bronchodilator response after two methods of salbutamol nebulization in asthmatic children. Advances in Dermatology and Allergology, 39(6), 1027-1034.
https://doi.org/10.5114/ada.2022.117038
10. Siddiqui, H., Siddiqui, S. A., Yadav, R. K., Singh, M. V., Kumar, D., Kumar, D., & Singh, D. K. (2022). Nebulized salbutamol with or without magnesium sulphate in the management of acute asthma in children in India: A randomized controlled trial. Journal of Tropical Pediatrics, 68(5).
https://doi.org/10.1093/tropej/fmac070
11. Kassab, M., Shdiefat, D., Hadoush, H., & Kanaan, S. (2022). Therapeutics effects of inhaled magnesium sulfate combined with adrenergic beta-2 agonist on children with acute asthma: Systematic review and meta-analysis. Journal of Pediatric Nursing, 64, e40-e51.
https://doi.org/10.1016/j.pedn.2022.01.007
12. Asif, R., Rais, H., Bai, P., & Aziz, R. (2024). Comparison of doses of nebulized magnesium sulphate as an adjuvant treatment with salbutamol in children with status Asthmaticus. Pakistan Journal of Medical Sciences, 40(5).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
